Fintel reports that on January 27, 2025, Morgan Stanley downgraded their outlook for Intellia Therapeutics (NasdaqGM:NTLA) ...

NAD, a vital molecule for cellular energy and DNA repair, plays a central role in aging and diseases like cancer and ...

Colossal Biosciences is now valued at over $10 billion and is working on ambitious projects to resurrect multiple long ...

This new tool, known as minimal, versatile genetic perturbation technology (mvGPT), combines the powers of gene editing, ...

Colossal Biosciences is working to bring back species like the woolly mammoth using CRISPR-Cas9 technology. The project aims to restore lost biodivers ...

In a Phase I/II trial, patients with X-linked chronic granulomatous disease will receive a treatment created using a new ...

New study reveals that TLE6 protein deficiency causes male infertility in mice. These findings suggest potential genetic ...

Advances in CRISPR technologies promise to accelerate the burgeoning pipeline of gene-editing therapies and broaden access to these disease-altering therapies.

Imagine a world where woolly mammoths roam the tundra once more—not in a prehistoric dream but as a living, breathing reality ...

It feels fantastic,” said Blau, who thanked her lab members and colleagues for their support and dedication. “This ...

Dylan Rees delves into how new research involving sterilised male mosquitos could benefit humans in preventing the spread of diseases.

Genetic changes are a significant cause of infertility, impacting over 15% of the global population. TLE6, a major protein ...